ライフサイエンスコーパス: urinary tract infection

1 , the only bacterial infection of concern is urinary tract infection.

2 cellular trap generation during experimental urinary tract infection.

3 nce type 131 (ST131) in treatment failure of urinary tract infection.

4 iously shown to be important in experimental urinary tract infection.

5 g empiric antibiotic therapy for a suspected urinary tract infection.

6 ing in children and adolescents with a first urinary tract infection.

7 s play highly coordinated roles in bacterial urinary tract infection.

8 ue damage seen in a mouse model of ascending urinary tract infection.

9 seminated infection including meningitis and urinary tract infection.

10 are test that can guide correct treatment of urinary tract infection.

11 antibiotic prophylaxis to prevent recurrent urinary tract infection.

12 a key factor for successful establishment of urinary tract infection.

13 step-down oral therapy to treat complicated urinary tract infections.

14 er hipA mutants cause multidrug tolerance in urinary tract infections.

15 non-spore-forming rod, are presented here as urinary tract infections.

16 sequent extra-intestinal infections, such as urinary tract infections.

17 ic E. coli (UPEC), causes most uncomplicated urinary tract infections.

18 and venous thromboembolic complications, and urinary tract infections.

19 ger hospital stay, and a higher incidence of urinary tract infections.

20 xazole, an antibiotic commonly used to treat urinary tract infections.

21 at least as common as clinically significant urinary tract infections.

22 ial strains that are commonly encountered in urinary tract infections.

23 fective endocarditis and catheter-associated urinary tract infections.

24 her rates of transient urinary retention and urinary tract infections.

25 cherichia coli (UPEC) are the chief cause of urinary tract infections.

26 and inguinal hernias but less than that for urinary tract infections.

27 ed intraabdominal infections, or complicated urinary tract infections.

28 (UPEC), which cause both acute and recurrent urinary tract infections.

29 arrhoea, injection-site nodules, nausea, and urinary tract infections.

30 tsS/BtsR importance during acute and chronic urinary-tract infections.

31 renal failure, 0.24 (95% CI, 0.09-0.39) for urinary tract infections, 0.21 (95% CI, 0.01-0.41) for s

32 renal failure, 1.10 (95% CI, 1.04-1.16) for urinary tract infections, 1.06 (95% CI, 1.00-1.11) for s

33 ons were 14 versus 7 for catheter-associated urinary tract infection, 13 versus 8 for ventilator-asso

34 us bacterial peritonitis (SBP) (645, 49.8%), urinary tract infection (151, 11.7%), and pneumonia (100

35 ryngitis (38 [14%] vs 36 [12%] vs 39 [15%]), urinary tract infection (19 [7%] vs 11 [4%] vs 13 [5%]),

36 e lowest was obstructive uropathy-associated urinary tract infection (26%).

37 a (4.5%), nonspecific chest pain (3.7%), and urinary tract infection (3.2%).

38 ratory tract infection (3 [7%] vs none], and urinary tract infections (3 [7%] vs 1 [2%]).

39 %]; men: 17 [7%] and 20 [8%] vs three [1%]), urinary tract infections (31 [6%] for both canagliflozin

40 ear, nose, and throat infections (55 [7%]), urinary tract infections (37 [5%]), and surgical-site in

41 (58.98% vs 14.81%; OR, 8.53; CI, 7.41-9.83), urinary tract infection (38.41% vs 8.60%; OR, 7.81; CI,

42 6 [7%] patients vs ALD403 7 [9%] patients), urinary tract infection (4 [5%] vs 1 [1%]), fatigue (3 [

43 ade >/=3 infections included pneumonia (8%), urinary tract infection (4%), and cellulitis (3%).

44 ), diarrhea (5.9% vs 3.1% respectively), and urinary tract infection (5.3% vs 3.9% respectively).

45 aturia (24 patients), urinoma (15 patients), urinary tract infection (8 patients), renal failure (7 p

46 00 for community-acquired pneumonia, 112 for urinary tract infection, 83 for intra-abdominal infectio

47 elop a point-of-care susceptibility test for urinary tract infection, a disease that 100 million wome

48 ower rates of ileus, Foley re-insertion, and urinary tract infection (all P < 0.01).

49 quired bloodstream infection, pneumonia, and urinary tract infection; all-cause ICU mortality; and le

50 dentification of microbial pathogens causing urinary tract infections allow prompt and specific treat

51 is of particular interest in the context of urinary tract infection analysis was also demonstrated.

52 best available therapy (137 with complicated urinary tract infection and 11 with complicated intra-ab

53 Recurrent or persistent urinary tract infection and clinical sepsis were signifi

54 Urinary tract infection and digestive system complicatio

55 We also extracted data for urinary tract infection and hospital admission for any r

56 marker most predictive of upper versus lower urinary tract infection and renal scarring.

57 ger percent burn and with the development of urinary tract infection and sepsis postadmission, regard

58 ceftazidime-avibactam (144 with complicated urinary tract infection and ten with complicated intra-a

59 variables assessed at the time of the first urinary tract infection and the development of renal sca

60 The risk of urinary tract infection and urinary retention after chem

61 History A 52-year-old man with a history of urinary tract infections and a previous clinical diagnos

62 to identify potential mechanisms leading to urinary tract infections and associated morbidities in b

63 Escherichia coli associated with urinary tract infections and bacteremia has been intensi

64 ts when used in the treatment of complicated urinary tract infections and complicated intra-abdominal

65 ance in mice with ascending Escherichia coli urinary tract infections and did not increase the bacter

66 23 individuals diagnosed with polymicrobial urinary tract infections and found that most interaction

67 well described for ExPEC strains that cause urinary tract infections and meningitis, they have not b

68 In addition, it resulted in a higher risk of urinary tract infections and need for transient self-cat

69 ome may be used to predict susceptibility to urinary tract infections and sepsis in burn patients.

70 extraintestinal sites to cause diseases like urinary tract infections and sepsis.

71 neral medical events (bacteremia, pneumonia, urinary tract infection), and cirrhosis-specific complic

72 ates of RTI, skin and soft-tissue infection, urinary tract infection, and bloodstream infection varie

73 gnoses as upper respiratory tract infection, urinary tract infection, and influenza-like illness occu

74 ose veins, inflammatory bowel disease (IBD), urinary tract infection, and preexisting diabetes were a

75 d bloodstream infection, catheter-associated urinary tract infection, and ventilator-associated pneum

76 and three outcome measures (pressure ulcers, urinary tract infections, and weight loss).

77 ons-including 32 with bacteremia and 15 with urinary tract infections-and 190 without bacterial infec

78 ng children with vesicoureteral reflux after urinary tract infection, antimicrobial prophylaxis was a

79 Lower urinary tract infections are among the most common human

80 Catheter-associated urinary tract infections are biofilm-mediated infections

81 Urinary tract infections are commonly caused by alpha-he

82 Urinary tract infections are considered among the most c

83 Urinary tract infections are one of the most common reas

84 Surgical site infections (SSIs), along with urinary tract infections, are among the most common infe

85 Using urinary tract infections as a model system, we demonstra

86 ant pathogens responsible for intestinal and urinary tract infections, as well as sepsis and hemolyti

87 Aerococcus urinae may cause urinary tract infections, bacteremia, and endocarditis.

88 ic reflux in children who have had a febrile urinary tract infection be reduced, but this approach is

89 ovel findings include clinically significant urinary tract infections by Actinomyces neuii (21%) and

90 Uropathogenic Escherichia coli cause urinary tract infections by adhering to mannosylated rec

91 d the role of fimbriae in implant-associated urinary tract infections by the Gram-negative bacterium

92 fumarate for 8 months presented with fever, urinary tract infection caused by Escherichia coli, anal

93 Urinary tract infections caused by uropathogenic Escheri

94 Urinary tract infections caused by uropathogenic Escheri

95 Catheter-associated urinary tract infection (CAUTI) is the commonest hospita

96 Catheter associated urinary tract infection (CAUTI) is the most common healt

97 alis, a leading cause of catheter-associated urinary tract infection (CAUTI), a source of significant

98 ilis, a leading cause of catheter-associated urinary tract infection (CaUTI), differentiates into swa

99 cluding endocarditis and catheter-associated urinary tract infection (CAUTI), is related to the abili

100 is an emerging cause of catheter-associated urinary tract infection (CAUTI), which frequently progre

101 welling catheter use and catheter-associated urinary tract infection (CAUTI).

102 e focused on the risk of catheter-associated urinary tract infections (CAUTI) caused by Escherichia c

103 Catheter-associated urinary tract infections (CaUTIs) are the most common ho

104 n detecting the onset of catheter-associated urinary tract infections (CAUTIs) is also demonstrated b

105 P. aeruginosa causes catheter-associated urinary tract infections (CAUTIs) through biofilm format

106 am infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated

107 During Escherichia coli urinary tract infections, cells in the human urinary tra

108 enic E. coli (UPEC) is the dominant cause of urinary tract infections, clinically described as cystit

109 ot associated with melanoma risk, except for urinary tract infections (CLL/SLL), localized scleroderm

110 selected HAIs, including catheter-associated urinary tract infection, Clostridium difficile infection

111 coli (UPEC), the primary causative agents of urinary tract infections, colonize and invade the epithe

112 Children with febrile urinary tract infection commonly have vesicoureteral ref

113 to infect the CBA/J mouse model of ascending urinary tract infection compared to that of the parent s

114 m and doripenem in patients with complicated urinary tract infection (cUTI), including acute pyelonep

115 The most common infections were urinary tract infection (cystitis) (34.9% vs 25.2%), cyt

116 Episodes of urinary tract infection (cystitis) occurred more often i

117 for most spending related to admissions for urinary tract infections, dehydration, heart failure, an

118 Recurrent urinary tract infection developed in 39 of 302 children

119 Our data reveal potential links for urinary tract infection development and several morbidit

120 Urinary tract infection did not affect the signature (P=

121 wardship in the era of increasing numbers of urinary tract infections due to extensively drug-resista

122 rence to study medication, or development of urinary tract infection during the study.

123 Vesicoureteral Reflux trial and the Careful Urinary Tract Infection Evaluation Study).

124 ed 32 ventilator-associated pneumonia, eight urinary tract infections, five blood stream infections,

125 minal Infections, Bone and Joint Infections, Urinary Tract Infections, Genital Infections, and Skin a

126 of abdominal pain, bloating, diarrhoea, and urinary tract infection [grade 3]; aneurysm [grade 4]),

127 The widespread occurrence of urinary tract infections has resulted in frequent antibi

128 Frequent antibiotic treatment of urinary tract infections has resulted in the emergence o

129 In human urinary tract infections, host cells release the antimic

130 Recent studies of acute urinary tract infections implicated invasion by Escheric

131 malaria in 10.5%, gastroenteritis in 10.3%, urinary tract infection in 5.9%, typhoid fever in 3.7%,

132 ary catheters (IUC) are the primary cause of urinary tract infection in acute care.

133 the bladder in the mouse model of ascending urinary tract infection in higher numbers than human com

134 es support 7 to 14 days of therapy for acute urinary tract infection in men.

135 nostic and therapeutic approach to pediatric urinary tract infection in the emergency department.

136 cherichia coli, the major causative agent of urinary tract infections in humans.

137 (UPEC) is the most common causative agent of urinary tract infections in humans.

138 h of nine antibiotics that are used to treat urinary tract infections in minutes.

139 Increased rates of Escherichia coli urinary tract infections, increasing resistance to ampic

140 a single site of infection (eg, complicated urinary tract infections, intra-abdominal infections), y

141 Urinary tract infection is among the most common reasons

142 Urinary tract infection is caused primarily by the quoru

143 strategy for patients suspected of having a urinary tract infection is to test for pyuria and bacter

144 ough the epidemiology of catheter-associated urinary tract infection is well-described, little is kno

145 Treatment of complicated urinary-tract infections is challenging due to rising an

146 t Escherichia coli and Enterococcus faecalis urinary tract infection isolates.

147 During experimental urinary tract infection, MAITs migrated to the bladder a

148 infection, ventilator-associated pneumonia, urinary tract infection, mean ventilator-free days, mean

149 In a murine urinary tract infection model, A-ICs bound uropathogenic

150 Moreover, in a murine urinary tract infection model, CFT073 infection rapidly

151 formation as well as attenuation in a murine urinary tract infection model.

152 oding a virulence factor in endocarditis and urinary tract infection models, has been shown to increa

153 h fimbriated, gram-negative Escherichia coli urinary tract infection (n=104); disease controls (n=19)

154 (n=10 [12%]), peripheral oedema (n=9 [11%]), urinary tract infections (n=9 [11%]), and orthostatic hy

155 ommon agent of sepsis and community-acquired urinary tract infections, obtained during the course of

156 rges by $3732.71 (P=.02), and higher rate of urinary tract infection (odds ratio=1.81; P=.05).

157 s with antibiotic-resistant Escherichia coli urinary tract infections (odds ratio [OR] = 4.19; 95% co

158 ailable therapy in patients with complicated urinary tract infection or complicated intra-abdominal i

159 ients were aged 18-90 years with complicated urinary tract infection or complicated intra-abdominal i

160 would not increase the risk of developing a urinary tract infection or increase the burden of use to

161 yuria and a diagnosis of a complicated lower-urinary-tract infection or pyelonephritis were randomly

162 treatment of patients with complicated lower-urinary-tract infections or pyelonephritis.

163 ofloxacin in patients with complicated lower-urinary-tract infections or pyelonephritis.

164 ions (OR = 7.0; CI, 1.7-28.3; P = .006), and urinary tract infection (OR = 0.04; CI, 0.3-0.9; P = .02

165 embolism (OR = 1.92, 95% CI: 1.08-3.43), and urinary tract infection (OR = 1.61, 95% CI: 1.02-2.54).

166 ty (OR, 5.24; 95% CI, 2.15-12.77), recurrent urinary tract infections (OR, 0.97; 95% CI, 0.27-3.45),

167 s, recurrent ear infections, chickenpox, and urinary tract infections (P < .0001).

168 wound infection, respiratory/renal failure, urinary tract infection, pneumonia, deep vein thrombosis

169 ection (SSI), deep/organ-space SSI, any SSI, urinary tract infection, pneumonia, sepsis, deep venous

170 nosis-Related Group codes for heart failure, urinary tract infection, pneumonia, septicemia, nutritio

171 ence of ESBL-related infections (bacteremia, urinary tract infections, pneumonia, central venous cath

172 Urinary tract infection-positive burn patients with alte

173 Since any urinary tract infection present on admission would not f

174 comprised rejection, acute tubular necrosis, urinary tract infection/pyelonephritis, viral nephritis,

175 nd no difference in complications, including urinary tract infection rates, between those using singl

176 ve complications from BPH, such as recurrent urinary tract infections, refractory urinary retention,

177 erichia coli (UPEC) are the primary cause of urinary tract infections, representing one of the most w

178 Women suffering from recurrent urinary tract infections (rUTIs) are routinely treated f

179 id and electrolyte disorders, renal failure, urinary tract infection, septicemia, and heat stroke wer

180 id and electrolyte disorders, renal failure, urinary tract infection, septicemia, and heat stroke.

181 12), headache (five and three vs eight), and urinary-tract infections (six and two vs two).

182 Urinary tract infections still remain a concern in febri

183 dependence, progressive renal insufficiency, urinary tract infection, stroke, venous thromboembolism,

184 her an E. faecalis or Pseudomonas aeruginosa urinary tract infection, suggesting a role for urinary a

185 cted from 12 dogs in three cohorts (healthy, urinary tract infection, TCC) and analyzed using liquid

186 In urinary tract infections, the E. coli ST131 clone seems

187 immune function, and decreased recurrence of urinary tract infections; the consumption of nuts and be

188 o group), diarrhoea (six [4%] vs nine [7%]), urinary tract infection (three [2%] vs nine [7%]), fall

189 both necessary and sufficient to control the urinary tract infection through iron sequestration, even

190 aspects of the innate immune response during urinary tract infection to facilitate bacterial invasion

191 niae causes a wide range of infections, from urinary tract infections to pneumonia.

192 nia, bacterial meningitis, yeast infections, urinary tract infections, tonsillectomy, childhood ear i

193 s: pneumonia, surgical site infection (SSI), urinary tract infection, transfusion/bleed events, and a

194 richia coli (UPEC), the predominant cause of urinary tract infections, undergoes a transient intracel

195 e, which had been standard treatment against urinary tract infections until widespread resistance dec

196 use only, particularly for outcomes such as urinary tract infection, urethral injury and quality of

197 , mortality, pneumonia, respiratory failure, urinary tract infection, urinary retention, anastomotic

198 e patients and in samples from patients with urinary tract infection using real-time reverse transcri

199 Urinary tract infection (UTI) (28.5%), and spontaneous b

200 tected escherichelin during clinical E. coli urinary tract infection (UTI) and experimental human col

201 be used to monitor the onset or prognosis of urinary tract infection (UTI) and some sexually-transmit

202 signaling networks controlled by CD14 during urinary tract infection (UTI) are unknown.

203 ed a household in which 2 young children had urinary tract infection (UTI) caused by an extended-spec

204 ts presented to the ED with an ICD 9/10 code urinary tract infection (UTI) diagnosis during July 2015

205 Providencia stuartii is associated with urinary tract infection (UTI) in catheterized patients.

206 Catheter-associated urinary tract infection (UTI) is a common device-associa

207 Urinary tract infection (UTI) is a frequent, serious com

208 Urinary tract infection (UTI) is a major global infectio

209 Urinary tract infection (UTI) is a very common infection

210 gnosis of asymptomatic bacteriuria (ASB) and urinary tract infection (UTI) is based on the presence o

211 Urinary tract infection (UTI) is most often caused by ur

212 Urinary tract infection (UTI) is one of the most common

213 The contribution of genetic variation to urinary tract infection (UTI) risk in children with vesi

214 lthy adult women with a history of recurrent urinary tract infection (UTI) to receive a single inject

215 For urinary tract infection (UTI), a history of two or more

216 Secondary outcomes were symptomatic urinary tract infection (UTI), all-cause death, all-caus

217 et for uropathogenic E. coli (UPEC)-mediated urinary tract infection (UTI), its contribution to UPEC

218 edominant etiological agent of uncomplicated urinary tract infection (UTI), manifested by inflammatio

219 The adjusted HRs of pneumonia, urinary tract infection (UTI), spontaneous bacterial per

220 tibiotic use for patients with a complicated urinary tract infection (UTI), we developed in a previou

221 ment of underlying ARD, and risk factors for urinary tract infection (UTI), were recorded.

222 sion in the kidney, we addressed its role in urinary tract infection (UTI), which remains largely unk

223 iption of uropathogens in women experiencing urinary tract infection (UTI)-like symptoms.

224 ory infection, intra-abdominal infection, or urinary tract infection (UTI).

225 he urinary tract mucosa and protects against urinary tract infection (UTI).

226 nterococcus was associated with Enterococcus urinary tract infection (UTI).

227 chia coli (UPEC) is the most common agent of urinary tract infection (UTI).

228 Streptococcus agalactiae can cause urinary tract infection (UTI).

229 with an established mouse model of bacterial urinary tract infection (UTI).

230 leting a course of antibiotics for a febrile urinary tract infection (UTI).

231 in vitro and disease severity in a model of urinary tract infection (UTI).

232 septic condition but has not been studied in urinary tract infection (UTI).

233 by Escherichia coli strains associated with urinary tract infection (UTI).

234 Neurogenic bladder predisposes to recurrent urinary tract infections (UTI) and renal failure, and su

235 esponsible for the majority of uncomplicated urinary tract infections (UTI) and represents the most c

236 Urinary tract infections (UTI) are common and represent

237 Urinary tract infections (UTI) are one of the most commo

238 oli (UPEC) is the major cause of 150 million Urinary Tract Infections (UTI) reported annually world-w

239 for E. coli isolates from community-acquired urinary tract infections (UTI) that occurred during the

240 richia coli (UPEC) accounts for 80 to 90% of urinary tract infections (UTI), and the increasing rate

241 s the major causative agent of uncomplicated urinary tract infections (UTI).

242 hia coli (UPEC), which cause the majority of urinary tract infections (UTI).

243 eteral complications (leak or stricture) and urinary tract infections (UTI).

244 ned susceptibility of clinical isolates from urinary tract infections (UTIs) after 15 min of exposure

245 Urinary tract infections (UTIs) and sexually transmitted

246 richia coli strains from 10 men with febrile urinary tract infections (UTIs) and their female sex par

247 Urinary tract infections (UTIs) are a common occurrence

248 Recurrent urinary tract infections (UTIs) are a common problem amo

249 Urinary tract infections (UTIs) are a major burden to hu

250 Urinary tract infections (UTIs) are a microbial disease

251 Urinary tract infections (UTIs) are among the most commo

252 Urinary tract infections (UTIs) are among the most commo

253 Urinary tract infections (UTIs) are among the most commo

254 Urinary tract infections (UTIs) are common after kidney

255 Urinary tract infections (UTIs) are common health-care-a

256 Urinary tract infections (UTIs) are common in both inpat

257 Urinary tract infections (UTIs) are frequent and lead to

258 Complicated urinary tract infections (UTIs) are frequent in immunosu

259 Urinary tract infections (UTIs) are frequently encounter

260 imiting and easily treated with antibiotics, urinary tract infections (UTIs) are often incompletely r

261 Urinary tract infections (UTIs) are one of the most comm

262 Urinary tract infections (UTIs) are potentially life thr

263 Urinary tract infections (UTIs) caused by E. coli ST131

264 Urinary tract infections (UTIs) caused by uropathogenic

265 Urinary tract infections (UTIs) caused by uropathogenic

266 es, and syrup) associated with prevention of urinary tract infections (UTIs) compared with placebo or

267 Urinary tract infections (UTIs) constitute a highly rele

268 ntibiotics for recurrent multidrug-resistant urinary tract infections (UTIs) disrupt the gut microbio

269 Asymptomatic bacteriuria and symptomatic urinary tract infections (UTIs) in older women are commo

270 Urinary tract infections (UTIs) occur predominantly in f

271 7% vs. 7.3%), pneumonia (7.6% vs. 3.8%), and urinary tract infections (UTIs) or pyelonephritis (24.5%

272 ble hematuria, migration, fragmentation, and urinary tract infections (UTIs) within 3 mo of transplan

273 ncluding vaginal infections, genital herpes, urinary tract infections (UTIs), and other sexually tran

274 of hospital-associated infections, including urinary tract infections (UTIs), bacteremia, and infecti

275 ExPEC causes the vast majority of urinary tract infections (UTIs), is a leading cause of a

276 Urinary tract infections (UTIs), predominantly caused by

277 Recurrent urinary tract infections (UTIs), primarily caused by uro

278 of enterococcal infections, particularly of urinary tract infections (UTIs), remains to be fully elu

279 During urinary tract infections (UTIs), uropathogenic Escherich

280 li (UPEC) is responsible for the majority of urinary tract infections (UTIs), which are some of the w

281 nd long durations of therapy for symptomatic urinary tract infections (UTIs), yet large-scale evaluat

282 (UPEC) bacteria are a causative pathogen of urinary tract infections (UTIs).

283 a significant number of catheter-associated urinary tract infections (UTIs).

284 herichia coli (UPEC) is the primary cause of urinary tract infections (UTIs).

285 (UPEC) is the primary cause of uncomplicated urinary tract infections (UTIs).

286 nths) and prevalence of antibiotic-resistant urinary tract infections (UTIs).

287 The aRRs were increased particularly for urinary tract infections (UTIs, 1.41; 95% CI, 1.35 to 1.

288 The effect of complications, such as urinary tract infection, venous thromboembolism, and myo

289 s a composite outcome of catheter-associated urinary tract infection, ventilator-associated pneumonia

290 oodstream infection, and catheter-associated urinary tract infection was 14.7 per 1000 ventilator-day

291 bles, being married or having a history of a urinary tract infection was associated with lower urinar

292 Prefecture, a large proportion of outpatient urinary tract infections was caused by well-recognized g

293 oli, the organism most responsible for acute urinary tract infections, was not the only or even the m

294 ter a first or second febrile or symptomatic urinary tract infection, we evaluated the efficacy of tr

295 ious adverse events; relapse, pneumonia, and urinary tract infection were the most common.

296 Urinary tract infections were more frequent in the onabo

297 as associated with more frequent episodes of urinary tract infections, whereas other infections occur

298 s unrelated to post-stroke pneumonia (mainly urinary tract infections), which were less frequent in t

299 ciated infection (81.5% of which represented urinary tract infection), while the remainder had health

300 herichia coli (UPEC), the principal cause of urinary tract infections worldwide.